Mercados españoles cerrados
  • Benzinga

    GSK's Blenrep Combo Therapy Cuts Risk Of Disease Progression Or Death By Around 50% In Pretreated Multiple Myeloma

    On Sunday, GSK plc (NYSE:GSK) released results from an interim analysis of the DREAMM-8 phase 3 head-to-head trial evaluating Blenrep (belantamab mafodotin) in combination with pomalidomide plus dexamethasone (PomDex), versus a standard of care, bortezomib plus PomDex for relapsed or refractory multiple myeloma. The data were presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. On the primary endpoint of progression-free survival (PFS), the belantamab mafodotin comb

  • Benzinga

    Why 1 In 3 Americans Report Having No Financial Concerns Whatsoever

    According to the Federal Reserve’s 2023 Economic Well-Being of U.S. Households study, many Americans feel financial uncertainty, but a surprising 31% of Americans report having no financial concerns. However, the detailed study released in May 2024 paints a concerning picture of Americans’ financial well-being. While 72% of respondents reported they were at least doing OK financially, this is a decrease from 73% in 2022 and a significant drop from the post-pandemic high of 78% in 2021. This mark

  • GlobeNewswire

    Fairfax India Announces Management Succession Plan

    NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, June 03, 2024 (GLOBE NEWSWIRE) -- Fairfax India Holdings Corporation (“Fairfax India” or the “Company”) (TSX: FIH.U) announces that Prem Watsa, Chairman of Fairfax India’s board since 2015 will step down as Chairman and Benjamin (Ben) Watsa will be appointed as Chairman of the Company’s board effective July 1, 2024. Prem will continue to serve on the board of directors of Fairfax India. Ben is the F